These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 3144697

  • 1. Growth of E mu-myc transgenic B-lymphoid cells in vitro and their evolution toward autonomy.
    Langdon WY, Harris AW, Cory S.
    Oncogene Res; 1988; 3(3):271-9. PubMed ID: 3144697
    [Abstract] [Full Text] [Related]

  • 2. The transgenic window on lymphoid malignancy.
    Adams JM, Harris AW, Vaux DL, Alexander WS, Rosenbaum H, Klinken SP, Strasser A, Bath ML, McNeall J, Cory S.
    Princess Takamatsu Symp; 1989; 20():297-309. PubMed ID: 2518688
    [Abstract] [Full Text] [Related]

  • 3. Transformation of bone marrow cells from E mu-myc transgenic mice by Abelson murine leukemia virus and Harvey murine sarcoma virus.
    Dyall-Smith D, Cory S.
    Oncogene Res; 1988 May; 2(4):403-9. PubMed ID: 2840624
    [Abstract] [Full Text] [Related]

  • 4. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.
    Strasser A, Harris AW, Bath ML, Cory S.
    Nature; 1990 Nov 22; 348(6299):331-3. PubMed ID: 2250704
    [Abstract] [Full Text] [Related]

  • 5. Survival and death of prelymphomatous B-cells from N-myc/bcl-2 double transgenic mice correlates with the regulation of intracellular Ca2+ fluxes.
    Zörnig M, Busch G, Beneke R, Gulbins E, Lang F, Ma A, Korsmeyer S, Möröy T.
    Oncogene; 1995 Nov 16; 11(10):2165-74. PubMed ID: 7478538
    [Abstract] [Full Text] [Related]

  • 6. A human immunoglobulin gene reduces the incidence of lymphomas in c-Myc-bearing transgenic mice.
    Nussenzweig MC, Schmidt EV, Shaw AC, Sinn E, Campos-Torres J, Mathey-Prevot B, Pattengale PK, Leder P.
    Nature; 1988 Dec 01; 336(6198):446-50. PubMed ID: 3143076
    [Abstract] [Full Text] [Related]

  • 7. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
    Yu D, Thomas-Tikhonenko A.
    Oncogene; 2002 Mar 14; 21(12):1922-7. PubMed ID: 11896625
    [Abstract] [Full Text] [Related]

  • 8. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.
    Vaux DL, Cory S, Adams JM.
    Nature; 1988 Sep 29; 335(6189):440-2. PubMed ID: 3262202
    [Abstract] [Full Text] [Related]

  • 9. AID and RAG1 do not contribute to lymphomagenesis in Emu c-myc transgenic mice.
    Nepal RM, Zaheen A, Basit W, Li L, Berger SA, Martin A.
    Oncogene; 2008 Aug 07; 27(34):4752-6. PubMed ID: 18408759
    [Abstract] [Full Text] [Related]

  • 10. E mu-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells.
    Strasser A, Harris AW, Cory S.
    Oncogene; 1993 Jan 07; 8(1):1-9. PubMed ID: 8423986
    [Abstract] [Full Text] [Related]

  • 11. E mu N- and E mu L-myc cooperate with E mu pim-1 to generate lymphoid tumors at high frequency in double-transgenic mice.
    Möröy T, Verbeek S, Ma A, Achacoso P, Berns A, Alt F.
    Oncogene; 1991 Nov 07; 6(11):1941-8. PubMed ID: 1658705
    [Abstract] [Full Text] [Related]

  • 12. Transgenic N-myc mouse model for indolent B cell lymphoma: tumor characterization and analysis of genetic alterations in spontaneous and retrovirally accelerated tumors.
    Sheppard RD, Samant SA, Rosenberg M, Silver LM, Cole MD.
    Oncogene; 1998 Oct 22; 17(16):2073-85. PubMed ID: 9798678
    [Abstract] [Full Text] [Related]

  • 13. H-2/myc, E mu/myc, and c-myc transgenic mice: potent sources of early hematopoietic cell lines.
    Roland J, Morello D.
    Cell Growth Differ; 1993 Nov 22; 4(11):891-900. PubMed ID: 8297795
    [Abstract] [Full Text] [Related]

  • 14. Acceleration of B-lymphoid tumorigenesis in E mu-myc transgenic mice by v-H-ras and v-raf but not v-abl.
    Langdon WY, Harris AW, Cory S.
    Oncogene Res; 1989 Nov 22; 4(4):253-8. PubMed ID: 2549487
    [Abstract] [Full Text] [Related]

  • 15. Interaction of abl and raf with IL-7 signaling pathway and transformation of pre-B cells from resistant mice.
    Hilbert DM, Theisen PW, Rudikoff EK, Bauer SR.
    Oncogene; 1998 Oct 22; 17(16):2125-35. PubMed ID: 9798684
    [Abstract] [Full Text] [Related]

  • 16. Lymphoproliferative syndrome associated with c-myc expression driven by a class I gene promoter in transgenic mice.
    Morello D, Lavenu A, Bandeira A, Portnoi D, Gaillard J, Babinet C.
    Oncogene Res; 1989 Oct 22; 4(2):111-25. PubMed ID: 2654814
    [Abstract] [Full Text] [Related]

  • 17. Lymphomagenesis in E mu-myc transgenic mice can involve ras mutations.
    Alexander WS, Bernard O, Cory S, Adams JM.
    Oncogene; 1989 May 22; 4(5):575-81. PubMed ID: 2657573
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. B-cell tumorigenesis in mice carrying a yeast artificial chromosome-based immunoglobulin heavy/c-myc translocus is independent of the heavy chain intron enhancer (Emu).
    Palomo C, Zou X, Nicholson IC, Bützler C, Brüggemann M.
    Cancer Res; 1999 Nov 01; 59(21):5625-8. PubMed ID: 10554044
    [Abstract] [Full Text] [Related]

  • 20. Cell populations during tumorigenesis in Eu-myc transgenic mice.
    Sidman CL, Shaffer DJ, Jacobsen K, Vargas SR, Osmond DG.
    Leukemia; 1993 Jun 01; 7(6):887-95. PubMed ID: 8501983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.